References
- MosherWDMartinexGMChandraAUse of contraception and use of family planning services in the United States: 1982–2002Adv Data200435013615633582
- FentonCWellingtonKMoenMDRobinsonDMDrospirenone/ethinylestradiol 3 mg/20 mcg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgarisDrugs2007671217481765
- BachmannGSulakPJSampson-LandersCEfficacy and safety of a low dose 24 day combined oral contraceptive containing 20 mcg ethinylestradiol and 3 mg drospirenoneContraception200470319119815325887
- Premenstrual dysphoric disorderFirstMBDiagnostic and Statistical Manual of Mental Disorders4th edWashington (DC)American Psychiatric Press2000771774
- SteinerMBornLDiagnosis and treatment of premenstrual dysphoric disorder: An updateInt Clin Psychopharmacol200015Suppl 3S5S1711195269
- YonkersKABrownCPearlsteinTBFoeghMSampson-LandersCRapkinAEfficacy of a new low dose oral contraceptive with drospirenone in premenstrual dysphoric disorderObstet Gynecol200510649250116135578
- KoltunWLuckyAThiboutotDEfficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris:a randomized, double-blind, placebo-controlled trialContraception20087724925618342647
- De LeoVMorganteGPiomboniPEvaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyper-androgenic women with polycystic ovary syndromeFertil Steril200788111311717418832
- Pérez-LopézFRClinical experiences with drospirenone: from reproductive to post-menopausal yearsMaturitas2008602789118468818
- KlippingCMarrJEffects of two combined oral contraceptives containing ethinyl estradiol 20 mcg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolismContraception20057140941615914128
- KoltunWLuckyAWThiboutotDEfficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trialContraception200877424925618342647
- DroegemullerWEndometriosis and adenomyosis: etiology, pathology, diagnosis and managementStencheverDroegemullerHerbstMichellComprehensive Gynecology2001531564
- HernadiLMarrJPetralgiaFEfficacy of a new low-dose 24-day combined oral contraceptive containing drospirenone 3 mg and ethinyl estradiol 20 μg [oral presentation] XVIII World Congress of Gynecology and Obstetrics (FIGO)2006115–10Kuala Lumpur
- PearlsteinTBBachmannGAZacurHATreatment of premenstrual dysphoric disorder with a new drospirenone containing oral contraceptive formulationContraception200572641442116307962
- CibulaDKarckUWeidenhammerHGKunzJAlinicicSMarrJEfficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20 mcg and drospirenone 3 mgClinical Drug Investig2006263143150
- WhiteWBHanesVKornerPDrospirenone and 17-B estradiol reduces 24 h BP in postmenopausal women with hypertensionObstet Gynecol200610723S24S